Product Image

Contributor Information

  • Name John Lunec
  • Institute Newcastle University

Tool Details

  • Tool name: N_N20R1 Cell Line
  • Tool type: Cell Lines
  • Tool sub-type: Continuous
  • Parental cell line: NGP
  • Organism: Human
  • Tissue: Lung
  • Cancer type: Neuroblastoma
  • Disease: Cancer
  • Model: Cancer Model
  • Conditional: No
  • Description: To determine how resistance to MDM2/p53 binding antagonists might develop, NGP cells were exposed to growth inhibitory concentrations of a MDM2 inhibitor, Nutlin-3, and a clonal resistant cell line was generated. The p53 mediated responses of the parental and resistant cell line were compared. In contrast to the parental cell lines, p53 activation by Nutlin-3, MI-63 or ionizing radiation was not observed in the NGP derived cell line, N_N20R1.
  • Research area: Cancer; Apoptosis and Programmed Cell Death; Cell Cycle; Drug Discovery & Development; Epigenetics & Nuclear Signalling
  • Production details: Resistant cell lines were established by exposing NGP cells to Nutlin-3. Single cell derived colonies were isolated with cloning cylinders and the clonal population expanded in culture medium containing the MDM2/p53 antagonist refreshed weekly for 60 days. Stage 1 resistant clones were then further exposed to increased concentrations of Nutlin-3 for 30 days to generate stage 2 resistant clones.

  • For Research Use Only

Target Details

Application Details

Handling

  • Format: Frozen
  • Storage conditions: Liquid Nitrogen
  • Shipping conditions: Dry ice
  • Mycoplasma free: Yes
  • Biosafety level: 1

Documentation

  • Available on request

References

  •   TP53 mutant MDM2-amplified cell lines selected for resistance to MDM2-p53 binding antagonists retain sensitivity to ionizing radiation.
  •   Drummond et al. 2016. Oncotarget. :. PMID: 27323823.